top of page
About Cellmover

Cellmover is a pre-clinical stage immunotherapy company committed to optimizing the tools of the immune system, with a vision to broaden the application of immunotherapies for various cancers.

cellmover
The technology

Cellmover has developed a library of peptides and nanobodies directed at specific proteins in T cells and NK cells.

 

By targeting these proteins, the peptides and nanobodies mediate increased survival and persistence of immune cells within the tumor microenvironment.

With support from
Members of
bottom of page